Northwestern Mutual Wealth Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-83
Closed -$1K 2811
2020
Q1
$1K Buy
+83
New +$1.04K ﹤0.01% 2506
2019
Q2
Sell
-95
Closed -$3K 2811
2019
Q1
$3K Buy
95
+79
+494% +$2.28K ﹤0.01% 2279
2018
Q4
$0 Buy
+16
New +$329 ﹤0.01% 2750
2017
Q2
Sell
-75
Closed -$3K 2222
2017
Q1
$3K Buy
75
+56
+295% +$1.78K ﹤0.01% 1823
2016
Q4
$0 Buy
+19
New +$371 ﹤0.01% 2399
2016
Q2
Sell
-273
Closed -$5K 2327
2016
Q1
$5K Buy
+273
New +$8.66K ﹤0.01% 1668

Other funds holding PTLA

Northwestern Mutual Wealth Management's PTLA Position: Q2 2020 in Review

Northwestern Mutual Wealth Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 83 shares — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in PTLA in Q1 2016 and held it in 6 quarters. The position peaked at $5K in Q1 2016. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Northwestern Mutual Wealth Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 83 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
  • Northwestern Mutual Wealth Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2016 and held it in 6 quarters.
  • Northwestern Mutual Wealth Management's Portola Pharmaceuticals, Inc. position peaked at $5K in Q1 2016.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.